AR100289A1 - FORMS OF A PI3K INHIBITOR - Google Patents
FORMS OF A PI3K INHIBITORInfo
- Publication number
- AR100289A1 AR100289A1 ARP150101368A ARP150101368A AR100289A1 AR 100289 A1 AR100289 A1 AR 100289A1 AR P150101368 A ARP150101368 A AR P150101368A AR P150101368 A ARP150101368 A AR P150101368A AR 100289 A1 AR100289 A1 AR 100289A1
- Authority
- AR
- Argentina
- Prior art keywords
- forms
- pi3k inhibitor
- purin
- quinolinyl
- pyridinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Abstract
Se proporcionan formas de hidrato y anhidrato de N-((1S)-1-(7-flúor-2-(2-piridinil)-3-quinolinil)etil)-9H-purin-6-amina. Se proporcionan además composiciones farmacéuticas que contienen las formas, y métodos para el uso de dichas composiciones para el tratamiento del cáncer.N - ((1S) -1- (7-fluorine-2- (2-pyridinyl) -3-quinolinyl) ethyl) -9H-purin-6-amine hydrate and anhydrate forms are provided. Pharmaceutical compositions containing the forms, and methods for the use of said compositions for the treatment of cancer are also provided.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461989383P | 2014-05-06 | 2014-05-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR100289A1 true AR100289A1 (en) | 2016-09-21 |
Family
ID=53190052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP150101368A AR100289A1 (en) | 2014-05-06 | 2015-05-06 | FORMS OF A PI3K INHIBITOR |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR100289A1 (en) |
TW (1) | TW201625621A (en) |
WO (1) | WO2015171725A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201813963A (en) | 2016-09-23 | 2018-04-16 | 美商基利科學股份有限公司 | Phosphatidylinositol 3-kinase inhibitors |
TW201815787A (en) | 2016-09-23 | 2018-05-01 | 美商基利科學股份有限公司 | Phosphatidylinositol 3-kinase inhibitors |
TW201825465A (en) | 2016-09-23 | 2018-07-16 | 美商基利科學股份有限公司 | Phosphatidylinositol 3-kinase inhibitors |
CN117916235A (en) * | 2021-08-11 | 2024-04-19 | 泰州亿腾景昂药业股份有限公司 | Cyclin dependent kinase inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0809141A2 (en) | 2007-03-23 | 2014-08-26 | Amgen Inc | COMPOUND, MANUFACTURE OF A MEDICINE, AND PHARMACEUTICAL COMPOSITION |
SI2834231T1 (en) | 2012-04-04 | 2016-09-30 | AmgenInc. | Heterocyclic compounds and their uses |
-
2015
- 2015-05-06 WO PCT/US2015/029413 patent/WO2015171725A1/en active Application Filing
- 2015-05-06 AR ARP150101368A patent/AR100289A1/en unknown
- 2015-05-06 TW TW104114430A patent/TW201625621A/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW201625621A (en) | 2016-07-16 |
WO2015171725A1 (en) | 2015-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016002027A1 (en) | Cyclopropylamine as an inhibitor of lsd1 | |
CL2018001230A1 (en) | Osteoarthritis treatment | |
EA201891024A1 (en) | TANK-BINDING KINASE INHIBITOR COMPOUNDS | |
ECSP17016797A (en) | INDAZOLES SUBSTITUTED WITH BENZYL AS BUB1 INHIBITORS | |
CL2016003422A1 (en) | Lysine specific demethylase-1 inhibitors | |
CL2016000807A1 (en) | Amino heteroaryl benzamides as kinase inhibitors. | |
CL2015002932A1 (en) | Protein kinase inhibitors | |
CO2017004525A2 (en) | Ror-gamma inhibitory dihydropyrrolopyridines | |
EA201691594A1 (en) | CYCLOPROPYLAMINES AS LSD1 INHIBITORS | |
CL2016003423A1 (en) | Lysine specific demethylase-1 inhibitors | |
CL2015001985A1 (en) | Thiazolcarboxamides and pyridinecarboxamide compounds, pim kinase inhibitors. | |
CL2016002495A1 (en) | Macrocyclic pyridine derivatives. | |
CL2018000596A1 (en) | New bicyclic compounds as atx inhibitors | |
DK3119762T3 (en) | BENZIMIDAZOLE DERIVATIVES AS ERBB-TYROSINE CHINASE INHIBITORS FOR THE TREATMENT OF CANCER | |
CL2015002151A1 (en) | Biaryl amide compounds as kinase inhibitors | |
EA201692203A1 (en) | TANK-BINDING KINAZ INHIBITING COMPOUNDS | |
CL2015002628A1 (en) | Heteroaryl compounds and their uses. | |
UY36175A (en) | 3-AMINO-1,5,6,7-TETRAHIDRO-4H-INDOL-4-ONAS | |
MX2016015565A (en) | Certain protein kinase inhibitors. | |
CL2012003415A1 (en) | Compounds derived from 2-oxo-piperidine and 1,1-dioxide-thiazine, mdm2 inhibitors; pharmaceutical composition that includes them; and its use for the treatment of cancer. | |
CL2016003214A1 (en) | Indolizine derivatives as phosphoinositide-3 kinase inhibitors | |
EA201690513A1 (en) | COMBINATION OF MEK INHIBITOR AND ERK INHIBITOR FOR USE IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES | |
CL2016003074A1 (en) | Compounds derived from 2-oxy-2-phenyl-n-5-pyrrolidin-3-ylamino-1,3,4-thiadiazol-2-ylacetamide, pharmaceutical composition gls1 inhibitors and their use to treat cancer. | |
BR112017000730B8 (en) | PYRROLIDINONE DERIVATIVES AS METAP-2 INHIBITORS, AND DRUGS | |
EA201790312A1 (en) | COMBINATION OF MEDICINES FOR THE TREATMENT OF MULTIPLE MYELOMA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |